摘要
目的:评价圣·约翰草提取物片(路优泰)上市后国内临床应用情况,为临床用药提供借鉴。方法:查阅国内外相关文献,对路优泰上市后国内临床使用的适应证、有效性、安全性、经济学等方面进行评价。结果与结论:路优泰目前已在国内广泛用于治疗轻、中度抑郁症,焦虑和烦躁不安等疾病,其临床应用在不断扩展。鉴于路优泰不良反应轻微、价格相对便宜,路优泰的应用前景将会更加广阔。
Objective: To do the post-marketing evaluation ofclinical application of St. John's Wort Extracts(Neurostan) in China, and provide the reference for clinical practice. Method: We searched the relevantliterature at domestic and abroad, and reviewed the indications, treatment efficacy, safety and cost-benefit of Neurosta after listing in China. Result and Conclusion: Neurostan has been widely used to treat mild to moderate depression, anxiety and restlessness in China. And its clinical applications are expanding. Due to less side effect and cheaper cost, applications of Neurostan will be broader in the future.
出处
《药品评价》
CAS
2016年第1期46-49,52,共5页
Drug Evaluation
关键词
圣·约翰草提取物片
路优泰
临床应用
上市后
St.John's Wort Extract
Neurostan
Clinical Application
Post-marketing